Back to Continuing Education

Want to buy for someone else? You can purchase a token at check out.

Overview
Goals and Outcomes
Details
Accreditations
Overview
Overview
The goal of this program is to improve the understanding of speech-language pathologists, therapists and nurses pertaining to confabulation.
Goals and Outcomes
Goals and Learning Outcomes
Speech-language pathologists, occupational and physical therapists, and nurses often work with clients suffering from traumatic brain injury, cerebrovascular accidents, or dementia. These conditions are frequently accompanied by confabulation, which may interfere with obtaining clients’ cooperation for nursing care and rehabilitation. The manner in which confabulatory behavior is managed can impact patient behavior. A specific approach may be appropriate for some individuals who confabulate, but may be ineffective or even counterproductive for others. Healthcare providers and caregivers may benefit from understanding the different types of confabulations, the situations in which they may occur, and how to manage them effectively.

 

The goal of this course is to inform speech-language pathologists, occupational and physical therapists, and nurses with knowledge of interdisciplinary assessments and interventions for confabulation.

 


After taking this course, you should be able to:

  • Define and describe at least five types of confabulation
  • Differentiate two formal and two informal measures of confabulation as well as describe strengths and limitations of these measures
  • Discuss two approaches for treating confabulation and at least one technique that is consistent with each approach
  • Define and describe at least five types of confabulation.
  • Identify two formal and two informal measures of confabulation.
  • Identify two approaches for treating confabulation and at least one technique that is consistent with each approach.

Course Termination Date: 06/03/23

Content Expiration Date: 05/31/23

Course Originally Released On: 05/01/19
Details
Course Details

Course Originally Released on : 5/1/2019

REL-ACU-0-CE709

Course Author

Elizabeth Kellerman

MSN, RN

Mary H. Purdy

PhD, CCC-SLP, BC-ANCDS

Anna Ver Hage

MSN, AGACNP-BC, CCRN, CNRN

George M. Fluharty

MA, CCC-SLP

Accreditations
Accreditations

NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Accreditations imageAccreditations image

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.